Knockdown of FUSE binding protein 1 enhances the sensitivity of epithelial ovarian cancer cells to carboplatin.

about

Knockdown of FUSE binding protein 1 enhances the sensitivity of epithelial ovarian cancer cells to carboplatin.

Item

http://www.wikidata.org/entity/Q47158563

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Knockdown of FUSE binding prot ...... n cancer cells to carboplatin.

@en

Knockdown of FUSE binding prot ...... n cancer cells to carboplatin.

@nl

type

Item

label

Knockdown of FUSE binding prot ...... n cancer cells to carboplatin.

@en

Knockdown of FUSE binding prot ...... n cancer cells to carboplatin.

@nl

prefLabel

Knockdown of FUSE binding prot ...... n cancer cells to carboplatin.

@en

Knockdown of FUSE binding prot ...... n cancer cells to carboplatin.

@nl

P1476

Knockdown of FUSE binding prot ...... n cancer cells to carboplatin.

@en

P2093

Huiling Zhang

http://www.w3.org/2001/XMLSchema#string

Jinli Zhang

http://www.w3.org/2001/XMLSchema#string

Libing Dai

http://www.w3.org/2001/XMLSchema#string

Peihong Liang

http://www.w3.org/2001/XMLSchema#string

Shengnan Qin

http://www.w3.org/2001/XMLSchema#string

Wenjuan Cao

http://www.w3.org/2001/XMLSchema#string

Xifeng Xiong

http://www.w3.org/2001/XMLSchema#string

Xing Hua

http://www.w3.org/2001/XMLSchema#string

Zhihe Liu

http://www.w3.org/2001/XMLSchema#string

P2860

A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif

JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress

Cancer statistics, 2001

Single-Stranded DNA-Binding Transcriptional Regulator FUBP1 Is Essential for Fetal and Adult Hematopoietic Stem Cell Self-Renewal

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Matrix metalloproteinases: regulators of the tumor microenvironment

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer--a new standard of care?

Localizing matrix metalloproteinase activities in the pericellular environment.

P304

5819-5824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.6978

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29113212

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5661610

http://www.w3.org/2001/XMLSchema#string